Cost Effectiveness and Cost Utility of Acetylcysteine versus Dimethyl Sulfoxide for Reflex Sympathetic Dystrophy

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.21, Iss.2, 2003-01, pp. : 139-148

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dimethyl sulfoxide preferred in reflex sympathetic dystrophy

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 398, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Dimethyl sulfoxide preferred in reflex sympathetic dystrophy

Inpharma, Vol. 1, Iss. 1373, 2003-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness and Cost-Utility of Beclomethasone/Formoterol versus Fluticasone Propionate/Salmeterol in Patients with Moderate to Severe Asthma

By Gerzeli Simone

Clinical Drug Investigation, Vol. 32, Iss. 4, 2012-04 ,pp. : 253-265

Adis International

Access to resources Recommend Favorite

Focus on cost-effectiveness, utility studies `could be a mistake'

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 364, 2002-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Cost Effectiveness and Cost Utility of Adjuvant Interferon in Cutaneous Melanoma: A Review

By Crott R.

PharmacoEconomics, Vol. 22, Iss. 9, 2004-01 ,pp. : 569-580

Adis International

Access to resources Recommend Favorite